- SUBSEQUENT EVENTS

6 Months Ended

Jul. 31, 2020

- SUBSEQUENT EVENTS [Abstract]

- SUBSEQUENT EVENTS

Note 9 - SUBSEQUENT EVENTS

In accordance with SFAS 165 (ASC 855-10) the Company has analyzed its operations subsequent to July 31, 2020 through the date these financial statements were issued and has determined that there were no material subsequent events to disclose in these financial statements.

VITASPRING BIOMEDICAL CO., LTD
SUPPLEMENTARY INFORMATION
SCHEDULE I - SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
THREE MONTHS ENDED APRIL 30, 2020 AND 2019
(UNAUDITED)
	Three months ended
	April 30, 2020	April 30, 2019
Bank charges	$                    85	$                 125
Depreciation expense	-	112
Office expense	510	18
Professional fees	17,150	13,156
Rent	-	1,410
Telephone	511	20
Total selling, general and administrative expenses	$            17,745	$            14,821